Vista Pharma.

Vista_Pharma.30 Apr 2024

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Vista Pharma.

Vista Pharma.

Pharmaceuticals

Vista_Pharma.30 Apr 2024

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
12-Jun-2015	S	Vista Pharmaceuticals Ltd has informed BSE about the outcome of Board Meeting held on June 11, 2015 The Board of Directors of Vista Pharmaceuticals Limited (The Company') at its meeting held on 09.10.2012 has approved the Scheme for Reduction of Share Capital. Accordingly number of shares shall be held by shareholders will be altered as under: A share holder who is holding 100 Equity Shares of Rs. 10/- each aggregating to Rs.1,000/- shall hold (after reduction) 166 shares of Rs. 11- each aggregating to Rs.332/-. Accordingly number of shares shall be held by shareholders will be altered as under: A share holder who is holding 100 Equity Shares of Rs. 10/- each aggregating to Rs.1,000/- shall hold (after reduction) 166 shares of Rs. 11- each aggregating to Rs.332/-. SUB. :- Reduction of Capital of Vista Pharmaceuticals Ltd. (Scrip Code: 524711) Trading members of the Exchange are hereby informed that, Vista Pharmaceuticals Ltd. has fixed the Record Date for the purpose of Reduction of Share Capital of the company pursuant to the order passed by the Hon'ble High Court of Andhra Pradesh and Telangana. COMPANY NAME & CODE Vista Pharmaceuticals Ltd. (524711) RECORD DATE 26/06/2015 PURPOSE Reduction of share capital : Pursuant to the scheme of reduction: the paid up share capital of Vista Pharmaceuticals Ltd. shall stand reduced from Rs. 15,00,00,000/- divided into 1,50,00,000 fully paid up equity shares of Rs.10/- each to Rs.5,00,00,000/- divided into 50,00,000 equity shares of Rs.10/- each, and, Thereafter, there shall be a split in the par value of the equity shares from Rs. 10/- each to Rs. 2/- per share. Illustration: A Shareholder of the company holding 100 equity shares of Rs. 10/- each , shall hold (after reduction) 166 equity shares of Rs.2/- each. NO DEALINGS FROM DATE & SETT. NO. 25/06/2015 DR-060/2015-2016 Trading Members are requested to take note of the above. (As Per BSE Notice Dated on 17.06.2015)	26-Jun-2015
10-Feb-2024	BC	Board Meeting Outcome	06-Mar-2024
13-Feb-2024	BC	Circular resolution	13-Feb-2024
02-Feb-2024	BC	VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve 1. Un-Audited financial results for	10-Feb-2024
10-Feb-2024	BC	Board Meeting Outcome Company Secretary Appointment disclosure	10-Feb-2024
30-Dec-2023	BC	Kindly note the allotment of 5,33,333 equity shares pursuant to the conversion of 5,33,333 warrants issued to others on a private placement	30-Dec-2023

No Rights has been declared by Vista_Pharma.

Book Closure

Record Date	Split Date	Purpose
06-Mar-2024	-	Board Meeting Outcome
13-Feb-2024	-	Circular resolution
10-Feb-2024	-	VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve 1. Un-Audited financial results for
10-Feb-2024	-	Board Meeting Outcome Company Secretary Appointment disclosure
30-Dec-2023	-	Kindly note the allotment of 5,33,333 equity shares pursuant to the conversion of 5,33,333 warrants issued to others on a private placement

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Vista Pharmaceuticals Ltd ₹14.00(0.00/0.00%)	14.00	+0.00	54.35	44.93	0.00	1.45
Astrazeneca Pharma India Ltd ₹5,341.25(-214.85/-3.87%)	5,341.25	-214.85	13,353.13	74.79	83.72	20.39
Bliss GVS Pharma Ltd ₹123.70(-0.75/-0.60%)	123.70	-0.75	1,295.03	61.27	18.97	1.32
Cipla Ltd ₹1,401.20(-6.35/-0.45%)	1,401.20	-6.35	113,132.18	53.64	34.40	4.37
Abbott India Ltd ₹26,415.75(+138.15/0.53%)	26,415.75	+138.15	56,133.47	17.43	49.00	18.06
Amrutanjan Health Care Ltd ₹697.95(-11.45/-1.61%)	697.95	-11.45	2,017.82	17.07	45.86	7.70

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	1.70	3.47	1.98	1.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1.70	3.47	1.98	1.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.02	0.08	0.13	0.40	0.00	0.00
Total Income	1.73	3.55	2.11	1.40	0.00	0.00
Total Expenditure	3.45	4.64	2.90	4.60	0.33	0.15
PBIDT	-1.72	-1.09	-0.79	-3.20	-0.33	-0.15
Interest	0.30	0.32	0.33	0.32	0.40	0.26
PBDT	-2.02	-1.41	-1.12	-3.52	-0.73	-0.41
Depreciation	0.18	0.18	0.17	0.16	0.15	0.15
Tax	0.00	0.00	0.00	-1.05	0.00	0.00
Deferred Tax	-0.57	0.43	-0.33	1.09	0.07	-0.32
Reported Profit After Tax	-1.63	-2.02	-0.95	-3.71	-0.96	-0.24
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-1.63	-2.02	-0.95	-3.71	-0.96	-0.24

EPS (Unit Curr.)	-0.33	-0.46	-0.23	-1.00	-0.27	-0.08
EPS (Adj) (Unit Curr.)	-0.33	-0.46	-0.23	-1.00	-0.27	-0.08
Calculated EPS (Unit Curr.)	-0.35	-0.46	-0.22	-0.99	-0.26	-0.07
Calculated EPS (Adj) (Unit Curr.)	-0.35	-0.46	-0.22	-0.99	-0.26	-0.07
Calculated EPS (Ann.) (Unit Curr.)	-1.39	-1.83	-0.89	-3.95	-1.04	-0.26
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-1.39	-1.83	-0.89	-3.95	-1.04	-0.26
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	9.38	8.84	8.55	7.51	7.36	7.36
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	2.00	2.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-101.18	-31.41	-39.90	-320.00	0.00	0.00
PBDTM(%)	-118.82	-40.63	-56.57	-352.00	0.00	0.00
PATM(%)	-95.88	-58.21	-47.98	-371.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	7.51	7.36	7.36	6.07	6.07	5.83
Reserves Total	23.04	28.09	25.49	23.57	27.25	26.03
Equity Share Warrants	6.16	0.00	0.00	0.00	2.48	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	36.71	35.45	32.85	29.64	35.80	31.86
Secured Loans	9.96	12.55	11.26	15.47	11.17	11.06
Unsecured Loans	0.00	0.00	-0.55	0.00	0.00	0.00
Total Debt	9.96	12.55	10.71	15.47	11.17	11.06
Total Liabilities	46.67	48.00	43.56	45.11	46.97	42.92
APPLICATION OF FUNDS :
Gross Block	26.76	25.74	25.72	25.72	24.24	20.02
Less : Accumulated Depreciation	7.02	6.41	5.79	5.06	3.71	2.35
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	19.74	19.33	19.93	20.66	20.53	17.67
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	9.33	9.08	9.08	8.78	8.54	7.11
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.02	0.03	0.04	0.02	0.03	0.02
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	7.68	9.33	9.68	9.68	11.25	10.91
Sundry Debtors	11.25	10.46	2.17	10.28	8.35	10.86
Cash and Bank	0.20	0.07	0.14	0.23	0.87	1.79
Loans and Advances	4.62	3.70	3.25	1.00	2.98	4.27
Total Current Assets	23.75	23.56	15.24	21.19	23.44	27.84
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	8.94	7.28	6.99	5.73	5.51	9.44
Provisions	0.36	0.24	0.24	0.24	0.24	0.58
Total Current Liabilities	9.30	7.51	7.23	5.96	5.74	10.02
Net Current Assets	14.45	16.05	8.01	15.22	17.70	17.82
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	2.64	3.48	0.00	1.95	1.09	1.58
Deferred Tax Liability	0.00	0.00	1.75	1.57	0.96	1.29
Net Deferred Tax	2.64	3.48	-1.75	0.38	0.13	0.29
Total Assets	46.18	47.97	35.31	45.06	46.92	42.91
Contingent Liabilities	0.00	0.00	0.00	0.00	3.99	1.56

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.07	0.14	0.23	0.87	1.79
Net Cash from Operating Activities	-1.71	-0.99	-6.75	0.80	3.30
Net Cash Used In Investing Activities	-1.27	-0.01	-0.30	-1.73	-5.65
Net Cash Used In Financing Activities	3.11	0.94	6.96	0.28	1.43
Net Inc./Dec In Cash And Cash Equivalents	0.13	-0.07	-0.09	-0.64	-0.92
Cash And Cash Equivalents At End Of The Year	0.20	0.07	0.14	0.23	0.87

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

35.44%

FII Shareholding

0.00%

DII Shareholding

0.04%

Public Shareholding

64.52%

**Promoter pledged shareholding 35.44%

About Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 54.35 crores. It has reported a sales of Rs. 1.7 crores and a net profit of Rs. -1.63 crores for the quarter ended December 2018. The company management includes Dhananjaya Alli, Dhananjaya Alli,G Narendra,M H Rao,Stanley Prabhakar Reddy,Umesh V Banakar,Chakravarthula Divya Bhavani,Umakanth Katta,Divakar Reddy Yerrabommanahalli,Murali Meraga,Pavan Sathvik Gilaka,Barkha Jain (Vista Pharmaceuticals Ltd) among others.

Chairman

Dhananjaya Alli

Registered office

Plot No 10to14 16to20 APIIC,Industrial Estate Chotyal,Nalgonda,Telangana,

FAX :91-08682-272551

Background

Incorporation Year1991

Face Value₹2

Market Lot1

How to buy Vista Pharma. shares on nse?

To buy Vista Pharma. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Vista Pharma. share price today?

The Vista Pharma. shares price on nse is Rs.14 today.

What is the market cap of Vista Pharma. shares on BSE ?

The company has a market capitalization of Rs.54.35Cr

What is the PE & PB ratio of Vista Pharma. shares ?

PE is 0 and PB is 1.45

What is the 52 Week High and Low of Vista Pharma. shares?

Vista Pharma. stock price high: Rs.19.7 Vista Pharma. stock price low: Rs.7.95